Industry
Biotechnology
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Loading...
Open
0.32
Mkt cap
1.3M
Volume
306K
High
0.34
P/E Ratio
N/A
52-wk high
8.11
Low
0.28
Div yield
N/A
52-wk low
0.02
Portfolio Pulse from
November 19, 2024 | 12:45 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 11:44 am
Portfolio Pulse from Benzinga Insights
October 24, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 02, 2024 | 12:17 pm
Portfolio Pulse from Benzinga Newsdesk
September 30, 2024 | 12:03 pm
Portfolio Pulse from Benzinga Newsdesk
September 09, 2024 | 12:44 pm
Portfolio Pulse from Benzinga Newsdesk
August 26, 2024 | 12:14 pm
Portfolio Pulse from Benzinga Newsdesk
August 20, 2024 | 1:28 pm
Portfolio Pulse from Benzinga Newsdesk
August 16, 2024 | 1:51 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.